Health Care REIT (NYSE: HCN) had its target price increased by Stifel Nicolaus from $64.00 to $67.00 in a report issued on Tuesday. They currently have a buy rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Barclays Capital initiated coverage on shares of Health Care REIT in a research note to investors on Tuesday, February 5th. They set an overweight rating and a $71.00 price target on the stock. Separately, analysts at Zacks reiterated a neutral rating on shares of Health Care REIT in a research note to investors on Friday, February 1st. They now have a $66.00 price target on the stock. Finally, analysts at JPMorgan Chase downgraded shares of Health Care REIT from an overweight rating to a neutral rating in a research note to investors on Wednesday, January 16th. They now have a $63.00 price target on the stock.
Five equities research analysts have rated the stock with a buy rating, one has assigned an overweight rating, and nine have given a hold rating to the company’s stock. The stock presently has an average rating of overweight and a consensus target price of $62.81.
Health Care REIT traded up 0.37% on Tuesday, hitting $64.25. Health Care REIT has a 52-week low of $52.40 and a 52-week high of $64.87. The stock’s 50-day moving average is currently $62.71. The company has a market cap of $16.659 billion and a price-to-earnings ratio of 64.72.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
